River stent
Phase 2- Indications
- Idiopathic intracranial hypertension
Company intelligence / Profile preview
Serenity Medical
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Serenity Medical has developed the first dedicated stent designed for treating venous sinus stenosis in patients with idiopathic intracranial hypertension. Their lead product, the River Stent, remains investigational and has not yet reached commercial availability. The company's leadership includes experienced inventors and entrepreneurs from the neurointerventional field.
- Therapeutic areas
- Neurology
- Modalities
- Device
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Serenity Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serenity Medical.